A Genomewide Association Study of Citalopram Response in Major Depressive Disorder-Reference-Cited by-同舟云学术

A Genomewide Association Study of Citalopram Response in Major Depressive Disorder

Published:2010-01 Issue:2 Volume:67 Page:133-138
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Garriock Holly A.,Kraft Jeffrey B.,Shyn Stanley I.,Peters Eric J.,Yokoyama Jennifer S.,Jenkins Gregory D.,Reinalda Megan S.,Slager Susan L.,McGrath Patrick J.,Hamilton Steven P.

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference29 articles.

1. The epidemiology of major depressive disorder: Results from the national comorbidity survey replication (NCS-R);Kessler;JAMA,2003

2. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice;Trivedi;Am J Psychiatry,2006

3. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees;Franchini;J Psychiatr Res,1998

4. Pharmacogenetic response to antidepressants in a multicase family with affective disorder;O'Reilly;Biol Psychiatry,1994

5. Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample;Peters;PLoS ONE,2008

Cited by 269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis;Translational Psychiatry;2024-07-19

2. AIDA-1/ANKS1B Binds to the SynGAP Family RasGAPs with High Affinity and Specificity;Journal of Molecular Biology;2024-06

3. Duloxetine improves chronic orofacial pain and comorbid depressive symptoms in association with reduction of serotonin transporter protein through upregulation of ubiquitinated serotonin transporter protein;Pain;2024-01-11

4. Research hotspots and trends in the relationship between genetics and major depressive disorder: A scientometric analysis from 2003 to 2023;Medicine;2023-12-22

5. Longitudinal early epigenomic signatures inform molecular paths of therapy response and remission in depressed patients;Frontiers in Molecular Neuroscience;2023-08-18